Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr
about
Cerebral ischemic events in patients with pancreatic cancer: A retrospective cohort study of 17 patients and a literature reviewEpidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial.Venous thromboembolism in cancer patients.Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case reportThe role of thromboprophylaxis in cancer patients: emerging data.Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Capecitabine in gastric cancer.System in biology leading to cell pathology: stable protein-protein interactions after covalent modifications by small molecules or in transgenic cells.Ramucirumab: successfully targeting angiogenesis in gastric cancer.Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Arterial and venous thrombosis in cancer patientsGastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy.CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.Factor V Leiden mutation triggering four major complications to standard dose cisplatin-chemotherapy for testicular seminoma: a case report.Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinomaPhase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancerPreoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.Cancer and coagulation.Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma.The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.Assessing risk of venous thromboembolism in the patient with cancer.Squamous cell carcinoma lung: Presented with bilateral lower limb deep venous thrombosis with gangrene formationVenous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis.Thrombophilic state in cancer, part I: biology, incidence, and risk factors.Management of venous thromboembolism in patients with cancer.Cancer-related venous thromboembolic disease: current management and areas of uncertainty.Engineered nanoparticles: thrombotic events in cancer.Emerging kinase inhibitors of the treatment of gastric cancer.Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study.The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients.Neoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism.Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers.
P2860
Q27314885-35962138-4F7B-4CE7-8339-B95C0762A8D2Q30317520-85096FE5-2A05-4B4B-8B95-632DFDF46B60Q33419213-1AD1B843-16EE-4178-9B9D-19E2C827D59AQ33520336-01ABAF98-1DF6-4164-825D-E9A7CCBC55CCQ33625063-0D7C5703-4061-49E4-9888-647D60FACE44Q33763866-DA70CC18-109E-4E0C-94CA-3554A0961012Q34236005-278085B1-1400-4115-B748-FC70A5B67C28Q34564273-315829BC-ACA1-4779-85A6-DFF35EC59854Q34616558-C27B5438-FF35-431B-B651-C22CF99A9AA5Q34620678-B8B41DAC-3D43-4036-9065-1B6DE1EA78E6Q34635182-BFC3DF39-5A60-4C7B-AC0D-E90138B30CC0Q34656353-B68B5A78-3D90-4306-926A-6ED4352AF9C6Q34761679-0239FFC2-779A-4D0D-99DD-F6A5318B2D15Q34771524-1466D262-828D-4B1F-9997-9E04E92F55E1Q35218582-F383FD2A-0D85-4254-B8B8-821468319F94Q35563035-5CF91158-CB2F-430A-87AB-43DF8EF61CFAQ35691049-10A37319-3347-4961-B3DB-799EE808E802Q35977197-1B0330CE-0481-4488-A678-7F7C6F523C9FQ36021874-D03023C6-6E9B-43E3-BEFA-A35F61968127Q36250714-1EDFDD02-DB28-439D-8ABD-0EC9E4BAEF4DQ36391554-552358F4-DAE6-4C98-BC2B-9C1A538FA69FQ36822182-D158ED18-EFFB-457D-B25E-BC4DB7ECDFD8Q37187791-E43B335E-D043-444F-9791-AD8D6F2479EDQ37393394-3D1C0551-6109-4250-B033-E578150F9D5DQ37422280-CC94FB7A-6A2D-4F65-AEB7-C261DBDE4042Q37609437-39167ADB-9B57-46B8-BC2C-FC968AD86BBEQ37845734-4634F243-67BD-44E6-B915-C0482EE84203Q37863640-4B603A0A-B23F-41B2-BF09-96D13CE4E4C4Q37903957-AA541A7B-35B1-4666-BDFB-57668DA8889FQ37998004-2C092ECD-976B-4AB7-B476-2565DF215F93Q38262939-AD52A8CF-0E2E-4DCA-9E74-F523BEDA5375Q38506084-C367C584-885F-43DB-8C0F-630EAB5EF7D8Q38565576-413FC19A-CCC9-47DB-AB19-9EA19945A075Q38645852-BA046FB0-D926-42D6-948A-5AE94ABB4FB6Q39017855-3DFE2C10-B558-4127-8D14-59B33B7678EAQ40217071-7BFD7799-9EDB-4B13-B2B5-99C944549DECQ41653912-531EC00C-D444-4713-92D4-9EC69F77A4B9Q41710487-15DD9661-E463-43FC-8093-BAA4F169F86DQ41729508-61D388D0-88A7-4332-BDC7-D6DC0374C013Q42126706-458FD3F8-E246-4CA9-9C00-1B8245C77F4B
P2860
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@ast
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@en
type
label
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@ast
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@en
prefLabel
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@ast
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@en
P2093
P356
P1476
Thromboembolism in patients wi ...... intestinal Clinical Studies Gr
@en
P2093
Andrew Richard Norman
Fareeda Coxon
Francis Daniel
Gary Middleton
Jacqueline Oates
Marianne Nicolson
Sheela Rao
Timothy Iveson
P304
P356
10.1200/JCO.2008.19.4274
P407
P577
2009-04-27T00:00:00Z